Dietary treatment in adults with refractory epilepsy
A review
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 12, 2014
- Accepted in final form August 20, 2014
- First Published October 29, 2014.
Article Versions
- Previous version (October 29, 2014 - 13:01).
- You are viewing the most recent version of this article.
Author Disclosures
- Pavel Klein, MBBChir,
- Ivana Tyrlikova, MD and
- Gregory C. Mathews, MD, PhD
- Pavel Klein, MBBChir,
Accorda,Inc: advisory board Eisai: advisory board UC Davis: DSMB, UC Davis Allopregnanolone TBI Clinical Trial (no compensation received to-date)
NONE
Speaker's bureau: UCB Pharma, Inc; Glaxo Smith Kline, travel expenses related to speaking Cyberonics: travel to a company-sponsored meeting
NONE
U.S. Patent Application No. 62/024,827 �KETOGENIC FOOD COMPOSITIONS AND USES THEREOF� Applicant: OH! MBF Reference No.: 207953-9003-US00 Application No. 62/024,827 The application was filed on July 15, 2014 (after the submission of the final revision of the present manuscript).The patent application is for use of ketogenic foods for various madical conditions.
NONE
Self-employed
NONE
Speaker's bureau: UCB Pharma, Inc; Glaxo Smith Kline; Eisai; Sunovion
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ivana Tyrlikova, MD and
NONE
NONE
NONE
NONE
NONE
NONE
1) Mid-Atlantic Epilepsy and Sleep Center,Clinical Research Associate, 1.5 year
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gregory C. Mathews, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to Dr. Klein: kleinp{at}epilepsydc.com
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.